top of page
Search
  • mmahomed2
    • Oct 7, 2015
    • 1 min read

NIH SBIR/STTR Commercialization Accelerator Program (CAP) for Phase II awardees

Valitor, Inc. has been selected into the 2015-16 NIH SBIR/STTR Commercialization Accelerator Program (CAP) for Phase II awardees. The CAP is a technical assistance program to help efficiently move NIH-funded technology towards commercialization. It is co-sponsored by the LARTA institute, which offers accelerator programs for entrepreneur and commercialization training to startup companies and university spin outs.

5 views0 comments

Recent Posts

See All

Valitor is proud to announce the final close of our Series A financing, co-lead by the Berkeley Catalyst Fund and ShangPharma Innovations. This round oversubscribed our initial offering, and we raised

Valitor has been awarded a Phase I SBIR grant from the National Cancer Institute. This project will support validation of our platform technology to generate long-acting immunotherapies that can provi

bottom of page